BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hermida M, Cassinotto C, Piron L, Aho-Glélé S, Guillot C, Schembri V, Allimant C, Jaber S, Pageaux GP, Assenat E, Guiu B. Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients. Cancers (Basel) 2020;12:E313. [PMID: 32013112 DOI: 10.3390/cancers12020313] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Hatzidakis A, Müller L, Krokidis M, Kloeckner R. Local and Regional Therapies for Hepatocellular Carcinoma and Future Combinations. Cancers (Basel) 2022;14:2469. [PMID: 35626073 DOI: 10.3390/cancers14102469] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Guiu B. Stereotactic body radiation therapy vs. radiofrequency ablation in HCC: comparing noncomparable data. J Hepatol 2020;73:727-8. [PMID: 32423631 DOI: 10.1016/j.jhep.2020.04.017] [Reference Citation Analysis]
3 Li FY, Li JG, Wu SS, Ye HL, He XQ, Zeng QJ, Zheng RQ, An C, Li K. An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study. J Hepatocell Carcinoma 2021;8:1375-88. [PMID: 34815974 DOI: 10.2147/JHC.S330746] [Reference Citation Analysis]
4 Guo ZY, Hong Y, Tu B, Cheng Y, Wang XM. Laparoscopic liver resection for hepatocellular carcinoma complicated with significant portal hypertension: A propensity score-matched survival analysis. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00050-9. [PMID: 35370090 DOI: 10.1016/j.hbpd.2022.03.012] [Reference Citation Analysis]
5 Gozzo C, Hermida M, Herrero A, Panaro F, Cassinotto C, Mohamad AM, Assenat E, Guillot C, Allimant C, Schembri V, Basile A, Dharancy S, Ursic-Bedoya J, Guiu B. Non-transplantable recurrence after percutaneous thermal ablation of ≤3-cm HCC: Predictors and implications for treatment allocation. Hepatol Commun 2022. [PMID: 35932178 DOI: 10.1002/hep4.2063] [Reference Citation Analysis]
6 Guiu B. MWA Versus RFA in HCC: Superior? Equivalent? Will We Ever Know? Cardiovasc Intervent Radiol 2020;43:1619-20. [PMID: 32909065 DOI: 10.1007/s00270-020-02635-x] [Reference Citation Analysis]
7 Guiu B, De Baère T, Noel G, Ronot M. Feasibility, safety and accuracy of a CT-guided robotic assistance for percutaneous needle placement in a swine liver model. Sci Rep 2021;11:5218. [PMID: 33664412 DOI: 10.1038/s41598-021-84878-3] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Ni Z, Wu B, Li M, Han X, Hao X, Zhang Y, Cheng W, Guo C. Prediction Model and Nomogram of Early Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation Based on Logistic Regression Analysis. Ultrasound Med Biol 2022:S0301-5629(22)00365-9. [PMID: 35690523 DOI: 10.1016/j.ultrasmedbio.2022.04.217] [Reference Citation Analysis]
9 Denys A, Guiu B, Chevallier P, Digklia A, de Kerviler E, de Baere T. Interventional oncology at the time of COVID-19 pandemic: Problems and solutions. Diagn Interv Imaging. 2020;101:347-353. [PMID: 32360351 DOI: 10.1016/j.diii.2020.04.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
10 Preel A, Hermida M, Allimant C, Assenat E, Guillot C, Gozzo C, Aho-Glele S, Pageaux GP, Cassinotto C, Guiu B. Uni-, Bi- or Trifocal Hepatocellular Carcinoma in Western Patients: Recurrence and Survival after Percutaneous Thermal Ablation. Cancers (Basel) 2021;13:2700. [PMID: 34070800 DOI: 10.3390/cancers13112700] [Reference Citation Analysis]
11 Hermida M, Preel A, Assenat E, Piron L, Cassinotto C, Ursic-Bedoya J, Guillot C, Herrero A, Panaro F, Pageaux GP, Guiu B. Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation. Hepatol Commun 2021;5:689-700. [PMID: 33860126 DOI: 10.1002/hep4.1661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Bouda D, Barrau V, Raynaud L, Dioguardi Burgio M, Paulatto L, Roche V, Sibert A, Moussa N, Vilgrain V, Ronot M. Factors Associated with Tumor Progression After Percutaneous Ablation of Hepatocellular Carcinoma: Comparison Between Monopolar Radiofrequency and Microwaves. Results of a Propensity Score Matching Analysis. Cardiovasc Intervent Radiol 2020;43:1608-18. [PMID: 32533309 DOI: 10.1007/s00270-020-02549-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Cassinotto C, Nogue E, Morell M, Panaro F, Molinari N, Guiu B. Changing trends in hepatocellular carcinoma management: Results from a nationwide database in the last decade. Eur J Cancer 2021;146:48-55. [PMID: 33582392 DOI: 10.1016/j.ejca.2021.01.009] [Reference Citation Analysis]
14 Han X, Dong J, Liu Z, Wu B, Tian Y, Tan H, Cheng W. Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study. International Journal of Hyperthermia 2020;37:1066-73. [DOI: 10.1080/02656736.2020.1817576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gomez F, Reimer P, Pereira PL, Bent C, Cazzato RL, Das M, Diamantopoulos A, Zeka B, Kaufmann N, Makris G. The Impact of COVID-19 on Interventional Radiology Practice Worldwide: Results from a Global Survey. Cardiovasc Intervent Radiol. [DOI: 10.1007/s00270-022-03090-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 An C, Jiang Y, Huang Z, Gu Y, Zhang T, Ma L, Huang J. Assessment of Ablative Margin After Microwave Ablation for Hepatocellular Carcinoma Using Deep Learning-Based Deformable Image Registration. Front Oncol. 2020;10:573316. [PMID: 33102233 DOI: 10.3389/fonc.2020.573316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Schembri V, Piron L, Le Roy J, Hermida M, Lonjon J, Escal L, Pierredon MA, Belgour A, Cassinotto C, Guiu B. Percutaneous ablation of obscure hypovascular liver tumours in challenging locations using arterial CT-portography guidance. Diagn Interv Imaging 2020;101:707-13. [PMID: 33012694 DOI: 10.1016/j.diii.2020.09.005] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Luerken L, Haimerl M, Doppler M, Uller W, Beyer LP, Stroszczynski C, Einspieler I. Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma. Rofo 2022. [PMID: 35545102 DOI: 10.1055/a-1768-0954] [Reference Citation Analysis]
19 Chen G, Chen H, Huang X, Cheng S, Zheng S, Wu Y, Zheng T, Chen X, Guo X, Zhang Z, Xie X, Zhang B. Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization. Medicina 2022;58:1016. [DOI: 10.3390/medicina58081016] [Reference Citation Analysis]